The unfortunate coincidence that HLA-DRB1*15:01 and HLA-DRB1*04:01 are enriched among MS patients and also constitute ADA risk factors likely contributes to the high incidence of IFNβ ADA among MS patients. Here, HLA-DRB1 is linked to myeloid sarcoma.